Monitored Dosage Systems
Wednesday 25th May 2022
The decision to supply / not supply MDS should be based on the best interest of the patient (as assessed by the community pharmacist) still as described in the 2017 letter. The pharmacist must where necessary provide reasonable adjustment however this is not always a MDS device.
A copy of the 2017 letter can be found below
CP Blister pack monitored dosage systems
Wednesday 25th May 2022